News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|April 11, 2023

Raising awareness on STDs

Author(s)Morgan Ebert, Managing Editor

Yasaswi Kislovskiy, MD, MSc, ob-gyn and reproductive infectious disease specialist, Allegheny Health Network, Pittsburgh, Pennsylvania, discusses the stigma around STDs/STIs and how clinicians can help spread awareness amongst their patients and their community.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

ByMorgan Ebert, Managing Editor

December 15th 2025

Oral zoliflodacin offers new option for gonorrhea treatment, says Edward Hook, MD

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

ByEdward Hook, MD

December 12th 2025

FDA approves Nuzolvence (zoliflodacin) for uncomplicated gonorrhea

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

ByMorgan Ebert, Managing Editor

December 12th 2025

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more

ByCeleste Krewson, Assistant Editor

December 12th 2025

Zoliflodacin demonstrated non-inferiority in adults and adolescents with gonorrhea | Image Credit: ©Giovanni Cancemi - stock.adobe.com.

Zoliflodacin demonstrated non-inferiority in adults and adolescents with gonorrhea

ByMorgan Ebert, Managing Editor

December 11th 2025

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

FDA grants 510(k) clearance to Revi System against urgency urinary incontinence

Heavy menstrual bleeding linked to iron deficiency in adolescents

HMI-115 shows promising pain relief in endometriosis patients

Late-stage cervical cancer risk higher in older women

© 2025 MJH Life Sciences^®

All rights reserved.